Learn more about Michael Mather
Michael is a Director based in our Bristol office. He specialises in healthcare valuations and general commercial valuation work, with extensive experience across pension fund valuations, residential development schemes and business rates advisory across the South, South West and South Wales.
He has over 25 years' experience delivering complex valuation projects, with particular expertise in hospitals and large industrial properties. His work spans diverse sectors, including healthcare estates, pension provider portfolios and development appraisals, providing strategic valuation advice to institutional clients and public sector organisations.
Prior to joining, Michael spent over two decades at Andrew Forbes, a BTG acquisition, and previously gained experience at a global commercial real estate agency, specialising in business rates, insolvency work, European valuations and commercial agency. He also worked within a commercial development company earlier in his career.
Office locations
Lower Castle Street, Bristol, BS1 3AG
View office detailsStay ahead with commentary on the latest sector trends, regulatory changes and market developments from our team of experts.
View all news and insights View all news and insights
BTG supports The Experiential Learning Group in its sale to Alchemist Group
BTG has supported The Experiential Learning Group (TELG) on its sale to Alchemist Group, the parent company behind a portfolio of best-in-class learning brands, forming a powerhouse in behaviour-based leadership and sales development.
US tariff reset erodes UK’s advantage as exporters prepare for the next regime
The Trump administration has replaced the reciprocal tariffs regime that was struck down by the Supreme Court with a non-discriminatory tariff tool, shifting tariff risk to a more uncertain carve-out-driven framework. In this new regime, the UK’s prior relative advantage for non-exempt goods is no longer assured and outcomes depend on sector carve-outs, product mix and enforcement.
David Hayton and David Abbott discuss the impact of high-end investment on the care sector
The UK care home sector attracted almost $2bn of US investment in the first half of 2025, expanding the number of luxury care home options in the process. Writing for Caring Times, David Hayton and David Abbott from BTG discussed the impact on the rest of the market, including the opportunity for revitalisation through renovation.
© 2026 BTG Consulting plc - Incorporated and registered in England and Wales - VAT Number: 880996072 - Company Registration Number: 05120043
This site uses cookies to monitor site performance and provide a mode responsive and personalised experience. You must agree to our use of certain cookies. For more information on how we use and manage cookies, please read our Privacy Policy.
